How to transfer my Mounjaro prescription to Texas

If you’re exploring GLP-1 medications like Wegovy, Ozempic, or Mounjaro for weight management, you’ve likely wondered: Can I actually get these prescribed through telehealth? The short answer is yes—and in most cases, it’s completely legal and safe. But as with many healthcare questions, the details depend on where you live and who’s prescribing.

This guide breaks down everything you need to know about accessing weight loss medications through telehealth in 2025, including federal and state-specific regulations, what to expect from your virtual visit, and how to identify trustworthy providers.

The Federal Rules: What’s Legal Nationwide?

Let’s start with the good news: federal law does not require an in-person visit before prescribing GLP-1 weight loss medications via telehealth.

Here’s why: medications like Wegovy (semaglutide 2.4mg), Ozempic (semaglutide), and Mounjaro (tirzepatide) are not controlled substances under the DEA’s Controlled Substances Act. The Ryan Haight Act—a federal law that typically requires an in-person exam before prescribing controlled medications online—simply doesn’t apply to these drugs.

This means a licensed healthcare provider can legally evaluate you through a video consultation and send an electronic prescription to your pharmacy, as long as they establish a valid patient-provider relationship and follow standard medical practices.

What About the DEA’s COVID-Era Flexibilities?

You may have heard about temporary telehealth rules during the pandemic. While those rules primarily affected controlled substances (like ADHD medications or certain pain medications), they reflect broader acceptance of telemedicine across healthcare.

As of December 2025, the DEA has extended its pandemic-era telehealth flexibilities for controlled substances through December 31, 2025. While this doesn’t directly impact non-controlled GLP-1 medications, it signals that federal regulators continue to support expanded telehealth access—and further extensions or permanent rules are expected in 2026.

Bottom line: For weight loss medications specifically, telehealth prescribing is fully permitted under federal law and shows no signs of changing.

Free consultations available with select providers only.

Get a free consultation

And find an affordable, caring specialist.

Find a provider

Free consultations available with select providers only.

State-Specific Requirements: Where It Gets Nuanced

While federal law greenlights telehealth for GLP-1 medications, individual states can add their own requirements. Some states mandate initial in-person exams, periodic follow-ups, or specific documentation for obesity treatment.

Let’s break down what you need to know by state category:

States With No In-Person Requirement

In these states, you can complete your entire weight loss journey via telehealth—from initial consultation through ongoing prescriptions:

• California
• Connecticut (requires behavioral counseling and lifestyle plan)
• Illinois
• New York
• Pennsylvania
• Washington

These states have embraced telehealth fully, recognizing that video consultations can establish appropriate patient-provider relationships for obesity treatment. Washington, in particular, has been a telehealth pioneer, though providers must now comply with the state’s My Health My Data Act for additional privacy protections.

States Requiring Initial In-Person Exams

Several states mandate at least one face-to-face visit before or shortly after starting telehealth treatment:

• Arkansas (strictest telehealth rules in the country)
• Delaware
• Georgia
• Mississippi
• New Jersey (requires comprehensive exam, labs, and counseling)
• North Dakota
• South Carolina
• Texas (clinical standards typically expect initial in-person)
• Utah
• Virginia (requires physical exam, labs, diet/exercise plan, plus 30-day follow-up)

Don’t let this discourage you. Many telehealth providers partner with local clinics or have hybrid models where you can complete your initial exam nearby, then continue care virtually. For example, Klarity Health works with a nationwide network of licensed providers who understand each state’s requirements and can coordinate any necessary in-person components seamlessly.

States With Special Follow-Up Rules

A few states impose specific monitoring requirements:

• Florida: Requires BMI ≥30 and mandates follow-up visits at least every 3 months during treatment
• Virginia: Requires a check-in within 30 days of starting therapy

These rules reflect good medical practice anyway—GLP-1 medications require monitoring for side effects and dose adjustments—so reputable telehealth providers already build this into their care models.

Who Can Prescribe Your Medication?

Physicians and Physician Assistants

All MDs (Medical Doctors) and DOs (Doctors of Osteopathic Medicine) can prescribe weight loss medications via telehealth in any state where they’re licensed. Physician Assistants (PAs) can also prescribe in every state, though most require physician supervision or a collaborative agreement.

Nurse Practitioners: Growing Independence

Nurse Practitioners (NPs) represent an increasingly important part of telehealth weight management. As of 2025, 34 states plus Washington, D.C. grant NPs full independent practice authority—meaning they can evaluate patients and prescribe medications without physician oversight.

States with independent NP practice include:

• California (after 3+ years experience)
• Connecticut (after 3 years collaboration)
• Delaware (after 2 years collaboration)
• New York (after 3,600 supervised hours)
• Utah (as of 2023)
• Virginia (after 2 years collaboration)
• Washington
• And many others

In states requiring collaborative practice, NPs work under agreements with supervising physicians. This doesn’t mean lower quality care—it’s simply a regulatory structure. States like Florida, Texas, Georgia, and Pennsylvania fall into this category.

Texas is notably strict: NPs must have formal physician agreements and cannot prescribe certain controlled substances independently (though again, GLP-1 medications are unaffected by this restriction).

When you connect with a telehealth provider like Klarity Health, you may see an NP or PA—this is completely normal and legal, as long as they’re appropriately licensed in your state.

What to Expect From Your Telehealth Visit

Legitimate telehealth weight loss programs follow rigorous clinical protocols. Here’s what a typical patient journey looks like:

Step 1: Comprehensive Medical History

You’ll complete a detailed questionnaire covering:

• Current height, weight, and BMI
• Medical conditions (especially thyroid issues, gallbladder disease, pancreatitis)
• Current medications and allergies
• Family history of thyroid cancer or Multiple Endocrine Neoplasia (MEN2)
• Previous weight loss attempts
• Mental health history
• Pregnancy status and plans

This isn’t a formality—GLP-1 medications have important contraindications. For example, you cannot take these drugs if you have a personal or family history of medullary thyroid carcinoma, are pregnant or planning pregnancy, or have certain gastrointestinal disorders.

Step 2: Live Video Consultation

A licensed provider will review your information, discuss your weight loss goals, and explain:

• How GLP-1 medications work (they’re incretin hormones that regulate appetite and blood sugar)
• Expected results (typically 10-15% body weight loss over several months)
• Common side effects (nausea, GI upset, possible gallstones)
• The importance of lifestyle changes alongside medication
• Treatment alternatives

This isn’t a rubber-stamp approval process. Good providers will assess whether you’re an appropriate candidate and may recommend lifestyle modifications instead if medication isn’t medically necessary.

Step 3: Treatment Plan and Prescription

If approved, your provider will:

• Send an electronic prescription to your preferred pharmacy
• Outline a titration schedule (starting doses and gradual increases)
• Provide injection training resources
• Schedule follow-up appointments

Important note on compounded medications: As of May 2025, the FDA has banned most compounded versions of semaglutide for weight loss due to safety concerns and resolution of medication shortages. Reputable telehealth providers only prescribe FDA-approved brand medications dispensed through licensed pharmacies—never ‘knock-off’ or overseas versions.

Step 4: Ongoing Monitoring

Expect regular check-ins:

• 1 month after starting: Assess tolerance, side effects, early weight changes
• Every 2-3 months thereafter: Review progress, adjust dosing, monitor for complications
• Lab work as needed: Some providers order baseline and periodic metabolic panels, A1C tests, or lipid profiles

States like Florida and Virginia legally mandate these follow-ups, but they represent standard medical care regardless of location.

Who Qualifies for GLP-1 Weight Loss Medications?

General Eligibility Criteria

FDA-approved indications for Wegovy (and off-label use of Ozempic/Mounjaro for weight management) include:

Adults with:

• BMI ≥30 (obesity), or
• BMI ≥27 with at least one weight-related condition such as:
• Type 2 diabetes
• High blood pressure
• High cholesterol
• Sleep apnea
• Cardiovascular disease

Plus:

• History of attempting lifestyle modifications (diet and exercise)
• No contraindications (see below)
• Commitment to ongoing lifestyle changes

Who Should NOT Take These Medications

You’re generally not a candidate if you have:

• Personal or family history of medullary thyroid carcinoma or MEN2 syndrome
• Current pregnancy or plans to become pregnant (must discontinue 2 months before conception)
• History of pancreatitis
• Severe gastroparesis or gastrointestinal disorders
• History of eating disorders (relative contraindication)
• Active gallbladder disease

Common Misconceptions

Myth: ‘Anyone can get Ozempic online for quick cosmetic weight loss.’

Reality: Reputable telehealth providers carefully screen for medical necessity. If you’re only slightly overweight without health complications, legitimate prescribers will recommend lifestyle changes first. These are powerful medications for people who genuinely need them—not casual diet aids.

Myth: ‘Telehealth weight loss services are less rigorous than in-person care.’

Reality: Quality telehealth programs follow the same clinical standards as traditional practices. In fact, many patients receive more consistent follow-up through structured telehealth programs than they might in busy brick-and-mortar clinics.

Navigating Insurance and Costs

Insurance Coverage

As of 2025, insurance coverage for GLP-1 weight loss medications remains inconsistent:

• Medicare Part D: Generally does not cover weight loss medications (federal law prohibition)
• Private insurance: Coverage varies widely; some plans cover Wegovy with prior authorization, others exclude it entirely
• Medicaid: Some state Medicaid programs now cover obesity medications (check your state)

Most telehealth providers can verify your insurance benefits before your visit. When medications aren’t covered, expect costs of:

• Wegovy: $1,300-$1,600/month without insurance
• Ozempic (off-label): $900-$1,000/month
• Mounjaro/Zepbound: $1,000-$1,200/month

Manufacturer Savings Programs

Both Novo Nordisk (Wegovy, Ozempic) and Eli Lilly (Mounjaro, Zepbound) offer savings cards that can significantly reduce out-of-pocket costs—sometimes to as low as $25/month—if you have commercial insurance. Telehealth providers can help you access these programs.

Cash-Pay Telehealth Services

Many telehealth weight loss programs offer transparent cash-pay pricing, bundling:

• Provider consultations
• Medication costs
• Ongoing support and monitoring

Platforms like Klarity Health accept both insurance and self-pay options, with clear upfront pricing—no surprise bills or hidden fees.

Red Flags: How to Spot Questionable Telehealth Providers

The popularity of GLP-1 medications has unfortunately attracted some bad actors. Protect yourself by avoiding services that:

🚩 Guarantee Prescriptions Without Evaluation

Any service promising ‘guaranteed approval’ or ‘automatic prescription after questionnaire’ is a red flag. Legitimate providers screen carefully and sometimes say no.

🚩 Sell Compounded or Overseas Medications

After the FDA’s May 2025 crackdown, compounded semaglutide should be extremely rare (allowed only in specific shortage situations with special pharmacy credentials). Be especially wary of:

• ‘Budget-friendly’ versions significantly cheaper than brand medications
• International pharmacies or medications shipped from overseas
• Services that don’t specify which exact medication you’ll receive

🚩 Skip Follow-Up or Monitoring

Weight loss medication management requires ongoing oversight. Avoid providers who:

• Don’t schedule follow-up appointments
• Never mention potential side effects or risks
• Don’t discuss lifestyle modifications
• Offer prescriptions with no monitoring plan

🚩 Lack Transparency About Credentials

Reputable telehealth platforms clearly state:

• Provider qualifications (MD, DO, NP, PA)
• State licenses and where providers are authorized to practice
• Company physical address and contact information

If you can’t easily find out who will be prescribing your medication or verify their credentials, look elsewhere.

✅ What Good Providers Look Like

Klarity Health and other reputable telehealth platforms:

• Require comprehensive medical history intake
• Conduct live video consultations with licensed, credentialed providers
• Clearly explain medications, alternatives, and expectations
• Prescribe only FDA-approved, pharmacy-dispensed medications
• Schedule regular follow-ups for monitoring
• Accept both insurance and cash-pay with transparent pricing
• Operate in compliance with all federal and state regulations

The Future of Telehealth Weight Management

Regulatory Trends to Watch

2026 and Beyond:

• The DEA is expected to extend or finalize rules on telehealth prescribing (affecting controlled substances, though not GLP-1s directly)
• The TREATS Act—bipartisan legislation to permanently expand telehealth access—may pass in 2026
• More states are considering full practice authority for NPs (bills pending in Mississippi, Pennsylvania, and others)
• Congress is discussing Medicare coverage expansions for obesity medications

What This Means for Patients:Telehealth access for weight management will likely become easier, not harder. Federal and state governments increasingly recognize that requiring in-person visits creates barriers for patients who need ongoing care—especially in rural areas or for people with mobility challenges.

New Medications on the Horizon

The GLP-1 landscape continues expanding:

• Zepbound (tirzepatide specifically for obesity) launched late 2023
• Oral GLP-1 options in development
• Combination therapies targeting multiple pathways

Telehealth platforms will adapt quickly to offer these new options as they receive FDA approval.

State-by-State Quick Reference

✅ Fully Telehealth-Friendly (No In-Person Required)

California, Connecticut, Illinois, New York, Pennsylvania, Washington

⚠️ Initial In-Person Visit Required

Arkansas, Delaware, Georgia, Mississippi, New Jersey, North Dakota, South Carolina, Texas, Utah, Virginia

📋 Special Follow-Up Rules

Florida (every 3 months), Virginia (30-day initial follow-up)

🩺 Independent NP Practice

California, Connecticut, Delaware, New York, Utah, Virginia, Washington (and 27 additional states)

🤝 NP Collaborative Practice Required

Arkansas, Florida, Georgia, Illinois, Mississippi, New Jersey, North Dakota, Pennsylvania, South Carolina, Texas

For detailed state-specific information, see the comprehensive table in the research section above.

Your Action Plan: Getting Started With Telehealth Weight Loss

Step 1: Verify Your Eligibility

Calculate your BMI and review the general criteria above. If you have weight-related health conditions or a BMI over 30, you’re likely a candidate.

Step 2: Choose a Reputable Provider

Look for telehealth platforms that:

• Are transparent about provider credentials and licensing
• Require comprehensive medical screening
• Offer live video consultations (not just questionnaires)
• Prescribe only FDA-approved medications
• Provide ongoing monitoring and support

Klarity Health checks all these boxes, with licensed providers available in most states who understand local regulations and work within compliant frameworks.

Step 3: Check State-Specific Requirements

Review whether your state requires an initial in-person exam. If so, ask potential telehealth providers how they coordinate this—many have partner clinics or hybrid models.

Step 4: Understand Costs Upfront

Before your consultation:

• Verify whether your insurance covers weight loss medications
• Ask about manufacturer savings programs
• Review cash-pay pricing if insurance doesn’t cover
• Confirm whether consultation fees are separate from medication costs

Step 5: Prepare for Your Consultation

Gather:

• Current medication list
• Medical history details
• Recent weight measurements
• Questions about treatment expectations and side effects

Step 6: Commit to the Process

GLP-1 medications are most effective when combined with:

• Reduced calorie intake (typically 1,200-1,500 calories/day)
• Regular physical activity (150+ minutes/week recommended)
• Behavioral changes and stress management
• Adequate sleep and hydration

Your telehealth provider will likely require you to engage with lifestyle support resources—this isn’t optional, it’s integral to success.

Final Thoughts

Telehealth has revolutionized access to evidence-based obesity treatment. For the first time, people across the country—including those in rural areas or with limited access to specialists—can receive expert weight management care from the comfort of home.

Yes, you can legally and safely get weight loss medications through telehealth. Federal law fully permits it, and while some states add specific requirements, none outright prohibit this model of care. The key is choosing a reputable provider that prioritizes clinical quality and regulatory compliance over quick profits.

As regulations continue evolving toward expanded access, patients can feel confident that telehealth weight management is here to stay. Whether you’re just beginning your weight loss journey or exploring medication options after other approaches haven’t worked, telehealth offers a convenient, effective pathway—when done right.

Ready to explore whether GLP-1 medications are right for you? Klarity Health offers consultations with experienced, licensed providers who can evaluate your needs, explain your options, and create a personalized treatment plan—all through secure video visits. With transparent pricing, insurance acceptance, and providers available nationwide, Klarity makes quality obesity care accessible when and where you need it.

Frequently Asked Questions

Q: Will my insurance cover telehealth weight loss medication visits?

A: Most insurance plans cover telehealth consultations at the same rate as in-person visits. However, coverage for the medications themselves varies widely—many commercial plans require prior authorization for Wegovy, while others exclude weight loss drugs entirely. Klarity Health can verify your benefits before your visit and help you navigate savings programs if insurance doesn’t cover medications.

Q: How quickly can I get a prescription?

A: If you’re medically eligible, most telehealth providers can send your prescription to the pharmacy within 24-48 hours of your consultation. However, due to ongoing medication supply constraints, your pharmacy may need several days to fill the prescription. Be patient—shortages have improved significantly in 2025 but haven’t completely disappeared.

Q: Are telehealth prescriptions for weight loss ‘legal’ or just a loophole?

A: They’re completely legal. These medications are not controlled substances, so federal law doesn’t restrict telehealth prescribing. States regulate the practice of medicine (ensuring proper evaluations and follow-up), but when done correctly, telehealth weight management is as legitimate as any other medical service.

Q: What if I move to a different state during treatment?

A: Your provider must be licensed in the state where you’re physically located at the time of service. If you move, you’ll need to either find a new provider licensed in your new state, or see if your current telehealth platform has providers licensed there. Many platforms (including Klarity Health) operate in multiple states to accommodate this.

Q: Can I just get medication without doing the lifestyle changes?

A: Technically, a provider could prescribe medication alone—but you won’t get optimal results, and many programs require participation in lifestyle support as part of treatment. These medications work best when combined with diet and exercise. Also, some state regulations (like Connecticut and Virginia) legally mandate that prescribers include lifestyle counseling as part of obesity treatment.

Q: What happens if I experience side effects?

A: Contact your provider immediately. Common side effects like nausea usually improve with time or dose adjustments, but serious issues (severe abdominal pain, signs of pancreatitis, allergic reactions) require prompt medical attention. Good telehealth platforms provide 24/7 access to clinical support or clear instructions for when to seek emergency care.

📅 RESEARCH CURRENCY STATEMENT
Verified as of: December 17, 2025
DEA Rules Status: DEA’s COVID-era telehealth flexibilities remain in effect through December 31, 2025. Non-controlled medications (like GLP-1 agonists) are not subject to the Ryan Haight Act’s in-person rule, so they can be prescribed via telehealth under federal law.
States Verified: AR, CA, CT, DE, FL, GA, IL, MS, NJ, NY, ND, PA, SC, TX, UT, VA, WA (as of Dec 2025)

References

1. U.S. Drug Enforcement Administration. ‘DEA and HHS Extend Telemedicine Flexibilities Through 2025.’ www.dea.gov, November 15, 2024.

2. Goldman, Arlette. ‘COVID-era telehealth prescribing extended for controlled substances.’ Axios, www.axios.com, November 18, 2024.

3. McDermott Will & Emery LLP. ‘DEA Extends Telemedicine Flexibilities for Controlled Substance Prescribing Through December 31, 2025.’ www.mwe.com, November 18, 2024.

4. Goodwin Procter LLP. ‘The Changing Regulatory and Reimbursement Landscape for Weight-Loss Drugs.’ www.goodwinlaw.com, March 27, 2024.

5. Nextech. ‘Know Your State’s Laws Around Semaglutide.’ www.nextech.com, April 11, 2025.

Source:

• https://www.axios.com/2024/11/18/covid-telehealth-prescribing-extended-adderall#:~:text=The%20Drug%20Enforcement%20Administration%20,year%20extension
• https://www.dea.gov/documents/2024/2024-11/2024-11-15/dea-and-hhs-extend-telemedicine-flexibilities-through-2025#:~:text=telemedicine%20flexibilities%20through%20December%2031%2C,HHS%20on%20November%2015%2C%202024
• https://www.mwe.com/insights/dea-signals-extension-of-telemedicine-flexibilities-for-controlled-substance-prescribing-for-2026/#:~:text=A%20new%20rule%20posted%20on,date%20of%20December%2031%2C%202025
• https://www.mwe.com/insights/dea-extends-telemedicine-flexibilities-for-controlled-substance-prescribing-through-december-31-2025/#:~:text=,a%20final%20set%20of%20regulations
• https://www.mwe.com/insights/dea-extends-telemedicine-flexibilities-for-controlled-substance-prescribing-through-december-31-2025/#:~:text=31%2C%202024.%20,In%20February%202023%2C%20the%20DEA
• https://www.mwe.com/insights/dea-extends-telemedicine-flexibilities-for-controlled-substance-prescribing-through-december-31-2025/#:~:text=to%20perform%20an%20in,rule%20regarding%20telemedicine%20prescribing%20of
• https://www.whitehouse.senate.gov/news/release/whitehouse-murkowski-warner-blackburn-urge-white-house-and-dea-to-extend-telehealth-flexibilities-for-substance-use-disorder-and-mental-health-treatment/#:~:text=Whitehouse%2C%20Murkowski%2C%20Warner%2C%20Blackburn%20Urge,substance%20use%20disorder%20treatment%20Washington
• https://natlawreview.com/article/arkansas-it-again-telemedicine-regulation-arkansas-undergoes-additional-change#:~:text=Arkansas%20currently%20has%20one%20of,person%20examination
• https://www.nextech.com/blog/semaglutide-laws-by-state#:~:text=Who%20can%20prescribe%20semaglutide%3F%20,
• https://natlawreview.com/article/arkansas-it-again-telemedicine-regulation-arkansas-undergoes-additional-change#:~:text=Arkansas%20currently%20has%20one%20of,encounter%20to%20establish%20a%20valid